Education
About Us
Working with TipRanks
Follow Us
COSMOS Pharmaceutical Corporation (JP:3349)
:3349
3349 Stock Chart & Stats
¥6699.00
¥109.00(1.60%)
At close: 4:00 PM EST
¥6699.00
¥109.00(1.60%)
Day’s Range― - ―
52-Week Range¥6,355.00 - ¥10,045.00
Previous CloseN/A
Volume659.40K
Average Volume (3M)399.89K
Market Cap
¥527.83B
Enterprise Value¥522.41B
Total Cash (Recent Filing)¥57.04B
Total Debt (Recent Filing)¥49.96B
Price to Earnings (P/E)22.8
Beta-0.20
Next Earnings
Jul 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.93%
Share Statistics
EPS (TTM)103.10
Shares Outstanding80,001,600
10 Day Avg. Volume586,980
30 Day Avg. Volume399,893
Financial Highlights & Ratios
PEG Ratio0.85
Price to Book (P/B)2.72
Price to Sales (P/S)0.69
P/FCF Ratio-814.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)401.44
Revenue Forecast (FY)¥1.08T
Bulls Say, Bears Say
Bulls Say
Revenue Growth & Margin StabilityConsistent top-line growth with stable gross and net margins signals a resilient retail model and disciplined pricing/merchandising. Over the next several months this durability supports predictable earnings, ongoing store-level profitability, and the ability to reinvest in inventory and customer experience without eroding unit economics.
Solid Balance SheetLow leverage, a strong equity ratio and robust ROE provide financial flexibility to fund store operations or strategic investments while absorbing shocks. This prudent capital structure supports steady execution of retail expansion and reduces refinancing vulnerability across the medium term.
Strong Operating Cash GenerationHealthy operating cash flow indicates the core drugstore operations convert sales into cash efficiently, supporting working capital, supplier terms, and reinvestment. Sustained operating cash generation underpins day-to-day liquidity and funds routine capital needs even if investing activity pressures free cash flow temporarily.
Bears Say
Negative Free Cash Flow TrendPersistent negative free cash flow implies reported earnings are not translating into surplus cash after investment. This restricts discretionary spending, may require external funding for growth or dividends, and increases sensitivity to rising borrowing costs or tighter credit conditions over coming quarters.
Rising Total DebtAlthough leverage remains moderate, an upward trend in total debt raises the risk that future interest and principal obligations could absorb cash flows. Continued debt accumulation without matching free cash flow improvement could constrain strategic flexibility and heighten refinancing risk in a higher-rate environment.
Pressure On EBIT MarginA recent dip in EBIT margin indicates emerging cost or mix pressures that could compress profitability if sustained. For a retail pharmacy, persistent margin erosion reduces capacity to fund store investments or absorb cost shocks, making margin recovery a medium-term priority for preserving returns.
COSMOS Pharmaceutical Corporation News
3349 FAQ
What was COSMOS Pharmaceutical Corporation’s price range in the past 12 months?
COSMOS Pharmaceutical Corporation lowest stock price was ¥6355.00 and its highest was ¥10045.00 in the past 12 months.
What is COSMOS Pharmaceutical Corporation’s market cap?
COSMOS Pharmaceutical Corporation’s market cap is ¥527.83B.
When is COSMOS Pharmaceutical Corporation’s upcoming earnings report date?
COSMOS Pharmaceutical Corporation’s upcoming earnings report date is Jul 10, 2026 which is in 110 days.
How were COSMOS Pharmaceutical Corporation’s earnings last quarter?
COSMOS Pharmaceutical Corporation released its earnings results on Oct 08, 2025. The company reported ¥103.1 earnings per share for the quarter, missing the consensus estimate of ¥112.021 by -¥8.921.
Is COSMOS Pharmaceutical Corporation overvalued?
According to Wall Street analysts COSMOS Pharmaceutical Corporation’s price is currently Overvalued.
Does COSMOS Pharmaceutical Corporation pay dividends?
COSMOS Pharmaceutical Corporation pays a Semiannually dividend of ¥37.5 which represents an annual dividend yield of 0.93%. See more information on COSMOS Pharmaceutical Corporation dividends here
What is COSMOS Pharmaceutical Corporation’s EPS estimate?
COSMOS Pharmaceutical Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does COSMOS Pharmaceutical Corporation have?
COSMOS Pharmaceutical Corporation has 80,001,600 shares outstanding.
What happened to COSMOS Pharmaceutical Corporation’s price movement after its last earnings report?
COSMOS Pharmaceutical Corporation reported an EPS of ¥103.1 in its last earnings report, missing expectations of ¥112.021. Following the earnings report the stock price went up 0.925%.
Which hedge fund is a major shareholder of COSMOS Pharmaceutical Corporation?
Currently, no hedge funds are holding shares in JP:3349
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
COSMOS Pharmaceutical Corporation
COSMOS Pharmaceutical Corporation operates a chain of drug stores in Japan. It also operates 1,130 stores in the Kanto, Chubu, Kansai, Chugoku, Shikoku, and Kyushu regions. The company was founded in 1983 and is headquartered in Fukuoka, Japan.
Technical Analysis
Sundrug Co
―
Sugi Holdings Co
―
TSURUHA Holdings
―
Create SD Holdings Co., Ltd.
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―
Options Prices
Currently, No data available
---